Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37114476)

  • 21. Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
    Muendlein A; Geiger K; Heinzle C; Gaenger S; Winder T; Severgnini L; Reimann P; Brandtner EM; Leiherer A; Drexel H; Decker T; Nonnenbroich C; Dechow T
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6435-6444. PubMed ID: 36763171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
    Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
    Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis.
    Liu Q; Li X; Li S; Qu S; Wang Y; Tang Q; Ma H; Luo Y
    Tumour Biol; 2016 Aug; 37(8):11421-7. PubMed ID: 27000756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
    Xu T; Zhang Y; Zhang J; Qi C; Liu D; Wang Z; Li Y; Ji C; Li J; Lin X; Hou T; Liu H; Zhang L; Han-Zhang H; Shen L; Wang X
    Front Oncol; 2020; 10():568911. PubMed ID: 33194656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of gene variation in All-
    Tao H; Shen M; Zhang X; Wang M; Wu Y; Sun H; Ling C; Yang Y; Chen K; Li D
    J Gastrointest Oncol; 2022 Dec; 13(6):3009-3024. PubMed ID: 36636055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
    Fernández Montes A; Alonso Orduña V; Asensio Martínez E; Rodríguez Salas N; Torres E; Cacho Lavín D; Rodríguez Alonso RM; Falcó E; Oliva JC; Cirera L; García Gómez J; Pericay C
    Oncologist; 2023 Oct; 28(10):e902-e909. PubMed ID: 37141400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
    Zhan J; Li X; Yu Z; Yuan YH; Hou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations.
    Venesio T; Balsamo A; Rondo-Spaudo M; Varesco L; Risio M; Ranzani GN
    Lab Invest; 2003 Dec; 83(12):1859-66. PubMed ID: 14691304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
    Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
    Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
    Wang D; Liang S; Zhang Z; Zhao G; Hu Y; Liang S; Zhang X; Banerjee S
    Oncotarget; 2017 Mar; 8(13):21327-21335. PubMed ID: 28423518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
    Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
    J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations.
    Cercek A; Braghiroli MI; Chou JF; Hechtman JF; Kemeny N; Saltz L; Capanu M; Yaeger R
    Clin Cancer Res; 2017 Aug; 23(16):4753-4760. PubMed ID: 28446505
    [No Abstract]   [Full Text] [Related]  

  • 36. Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
    Kim B; Won D; Jang M; Kim H; Choi JR; Kim TI; Lee ST
    BMC Med Genomics; 2019 Jul; 12(1):103. PubMed ID: 31269945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.
    Chiang JM; Wu Chou YH; Ma SC; Chen JR
    Virchows Arch; 2004 Nov; 445(5):465-71. PubMed ID: 15449054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
    Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
    Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
    Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
    Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
    Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
    BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.